@proceedings {7691,
	title = {Effet de l\&rsquo;administration de chlorure de nickel associe avec le selenium sur les param{\`e}tres hematologiques et la glande surr{\'e}nale chez le rat wistar},
	journal = {les 14{\`e}me journ{\'e}es nationales du d{\'e}partement de pharmacie :les m{\'e}thodes d{\textquoteright}analyse de l{\textquoteright}industrie pharmaceutique et en milieu Hospitalier.26,27/04/},
	year = {2016},
	author = {Asma Saouli}
}
@proceedings {7690,
	title = {Effet de l\&rsquo;administration de chlorure de nickel associe avec le selenium sur les param{\`e}tres hematologiques et la glande surr{\'e}nale chez le rat wistar},
	journal = {les 14{\`e}me journ{\'e}es nationales du d{\'e}partement de pharmacie :les m{\'e}thodes d{\textquoteright}analyse de l{\textquoteright}industrie pharmaceutique et en milieu Hospitalier.26,27/04/},
	year = {2016},
	address = {Batna, Alg{\'e}rie},
	author = {Asma Saouli and Ounassa Adjroud and Boulila, Ismah{\`e}ne and Salah, imene and Anfal Fedala}
}
@proceedings {65665,
	title = {Hexavalent Chromium-induced Changes in Biochemical Parameters of Wistar Albino Rats},
	journal = {International Conference on Biological and Chemical Processes (ICBCP), 25-26 April},
	year = {2016},
	month = {2016},
	address = {PARIS, FRANCE},
	abstract = {Potassium dichromate (K2Cr2O7) is one of the most toxic elements to which man can be exposed at work or in the environment. The purpose of the current work is to compare the effect of K2Cr2O7 using variations in the dose, route of administration and duration of exposure in male and female Wistar albino rats with a special focus on biochemical parameters. K2Cr2O7 was subcutaneously administered alone (10, 50 and 100 mg/kg body weight) to female Wistar albino rats. Male rats received in their drinking water K2Cr2O7 30 mg/L/day) for 20 consecutive days. The Biochemical parameters were evaluated on days 3, 6 and 21 after subcutaneous (sc.) treatment in female rats and on days 10 and 20 after oral administration in male rats. The subcutaneous (s.c.) administration of 25 mg/kg of K2Cr2O7 to Wistar albino rats induced a slight change in plasma glucose levels during the experiment period. On the contrary, a significant decrease in plasma glucose levels was observed with 50 mg/kg mainly on days 3 (-26\%) and 21 (-48\%) after treatment compared to controls females rats. On the other hand, the higher dose provoked a significant increase in plasma glucose concentrations on days 6 (+31\%) and 21 (+60\%). similarly, the lower dose of chromium had no effect on the plasma urea levels. Conversely, a significant increase (122\%) in this parameter was obtained during the first three days after treatment. In addition, a significant decrease in plasma glucose levels was observed with 50 mg/kg mainly on days 3 (-26\%) and 21 (-48\%) after treatment. On the other hand, the higher dose provoked a significant increase in plasma glucose concentrations on days 6 (+31\%) and 21 (+60\%). similarly, the lower dose of chromium had no effect on the plasma urea levels. Conversely, a significant increase in this parameter (122\%) was obtained during the first three days after treatment. In addition, administration of 100 mg/kg of K2Cr2O7 by s.c markedly augmented the levels of plasma urea on days 3 (62\%) and 6 (121\%). Administration of 30 mg/L/day of K2Cr2O7 in the drinking water induced a significant augmentation in both of plasma glucose (27\%) and urea (126\%) during the first ten days of treatment. These results suggested that K2Cr2O7 administered subcutaneously or in the drinking water may induce harmful effects on biochemical parameters. Keywords : glucose, potassium dichromate, Wistar albino rat, urea.},
	author = {Ounassa Adjroud}
}
@proceedings {65422,
	title = {Effets de l\&$\#$39;administration par voie sous- cutan{\'e}e du nickel associe avec le zinc et le selenium sur l\&$\#$39;uremie et le determinisme de la reproduction chez les rates gestantes},
	journal = {Premier colloque International de Toxicologie et Sant{\'e}. 28-29 novembre},
	year = {2016},
	month = {2016},
	address = {GUELMA, ALGERIE},
	author = {Imane Salah and Ounassa Adjroud and Ismahene BOULILA and Anfal Fedala and Asma Saouli}
}
@proceedings {6354,
	title = { Evaluation du rpotocole R C2H2OPA dans le lymphome m{\'e}diastinalprimitif {\`a} grande},
	journal = {Congr{\`e}s maghr{\'e}bin d{\textquoteright}H{\'e}matologie , Mai},
	year = {2016},
	address = {Alger, Alg{\'e}rie},
	author = {F Kacha and F Soltani and M Aiche and M Saidi}
}
@conference {6353,
	title = { Lymphome osseux primitif ;{\`a} propos d\&rsquo;un cas},
	booktitle = {Congr{\`e}s maghr{\'e}bin d{\textquoteright}H{\'e}matologie , Mai },
	year = {2016},
	author = {F Kacha}
}
@conference {6352,
	title = { Lymphome osseux primitif ;{\`a} propos d\&rsquo;un cas},
	booktitle = {Congr{\`e}s maghr{\'e}bin d{\textquoteright}H{\'e}matologie , Mai },
	year = {2016},
	address = {Alger, Alg{\'e}rie},
	author = {F Kacha and F Soltani and M Aiche and M Saidi}
}
@proceedings {6351,
	title = {LNH {\`a} grandes cellules B et foie },
	journal = {Congr{\`e}s maghr{\'e}bin d{\textquoteright}H{\'e}matologie , Mai },
	year = {2016},
	address = {Alger, Alg{\'e}rie},
	author = {M Aiche and F Soltani and F Kacha and M Saidi}
}
@proceedings {6350,
	title = {Evaluation des r{\'e}ponses mol{\'e}culaires chez des patients atteints de LMC trait{\'e}s par IMATIB en premi{\`e}re intention},
	journal = {Congr{\`e}s maghr{\'e}bin d{\textquoteright}H{\'e}matologie , Mai },
	year = {2016},
	address = {Alger, Alg{\'e}rie},
	author = {F Kacha and F Soltani and M Aiche and M Saidi}
}
@proceedings {6348,
	title = {Aspects {\'e}pid{\'e}miologique et clinique du lymphome diffus {\`a} grandes cellules B selon les facteurs de l\&rsquo;index pronostique international (IPI) },
	journal = {Congr{\`e}s maghr{\'e}bin d{\textquoteright}H{\'e}matologie , Mai },
	year = {2016},
	address = {Alger, Alg{\'e}rie},
	author = {M Aiche and F Soltani and M Saidi}
}
@proceedings {6347,
	title = {Evaluation des r{\'e}ponses mol{\'e}culaires chez des patients atteints de LMC trait{\'e}s par IMATIB en premi{\`e}re intention },
	journal = {Congr{\`e}s maghr{\'e}bin d{\textquoteright}H{\'e}matologie , Mai },
	year = {2016},
	address = {Alger, Alg{\'e}rie},
	author = {F Kacha and F Soltani and M Aiche and M Saidi}
}
@proceedings {6346,
	title = {Description des effets secondaires li{\'e}s {\`a}l\&rsquo;Imatib dans la leuc{\'e}mie myeloide chronique},
	journal = {Congr{\`e}s maghr{\'e}bin d{\textquoteright}H{\'e}matologie , Mai },
	year = {2016},
	address = {Alger, Alg{\'e}rie},
	author = {F Kacha and F Soltani and M Saidi}
}
@proceedings {6345,
	title = {Description de deux cas de LMC pr{\'e}c{\'e}d{\'e}s de tumeur solide},
	journal = {Congr{\`e}s maghr{\'e}bin d{\textquoteright}H{\'e}matologie , Mai },
	year = {2016},
	address = {Alger, Alg{\'e}rie},
	author = {F Kacha and F Soltani and M Saidi}
}
@proceedings {6322,
	title = {Contribution {\`a} l\&rsquo;{\'e}tude de la biodiversit{\'e} entomologique de l\&rsquo;Abricotier dans la r{\'e}gion de Batna-Alg{\'e}rie},
	journal = {10th Maghrebian Congess on Marine Sciences and the 5th Franco-Maghrebian Congress of Zoology \& Ichthyology},
	year = {2016},
	address = {F{\`e}s, Maroc},
	author = {CHAFAA Smail}
}
@proceedings {6289,
	title = {Contribution {\`a} la recherche des effets du nickel administr{\'e} par voie sous-cutan{\'e}e et son {\'e}ventuelle interaction avec le s{\'e}l{\'e}nium et le zinc sur la leucopo{\"\i}{\`e}se et l\&rsquo;histologie h{\'e}patique},
	journal = {Les 14 {\`e}mes journ{\'e}e nationales de d{\'e}partement de pharmacie {\textendash}.les m{\'e}thodes d{\textquoteright}analyse en milieu hospitalier,{\'e}tat des lieux et perspectives d{\textquoteright}avenir,  27 _28 Avril },
	year = {2016},
	address = {Batna, Alg{\'e}rie},
	author = {Anfal Fedala and Ounassa Adjroud and Salah, Im{\`e}ne and Asma Saouli and Boulila, Ismah{\`e}ne}
}
@proceedings {6288,
	title = {Effet d\&rsquo;administration du chlorure de nickel associ{\'e} avec le s{\'e}l{\'e}nium sur les param{\`e}tres h{\'e}matologiques et la glande surr{\'e}nale chez le rat wistar},
	journal = {Les 14 {\`e}mes journ{\'e}e nationales de d{\'e}partement de pharmacie {\textendash}.les m{\'e}thodes d{\textquoteright}analyse en milieu hospitalier,{\'e}tat des lieux et perspectives d{\textquoteright}avenir,  27 _28 Avril },
	year = {2016},
	address = { Batna, Alg{\'e}rie},
	author = {SAOULI ASMA}
}
@proceedings {6272,
	title = {Effets de l\&$\#$39;administration par voie sous- cutan{\'e}e du nickel associe avec le zinc et le selenium sur l\&$\#$39;uremie et le determinisme de la reproduction chez les rates gestantes},
	journal = {Premier colloque International de Toxicologie et Sant{\'e}. 28-29 novembre },
	year = {2016},
	address = { GUELMA, ALGERIE},
	author = {Salah Imane}
}
@proceedings {6268,
	title = {Hexavalent Chromium-induced Changes in Biochemical Parameters of Wistar Albino Rats},
	journal = {Engineering for Life Sciences and Biomedicine" April 25-26,  2016},
	year = {2016},
	address = { PARIS, FRANCE},
	author = {Ounassa Adjroud}
}
@article {6256,
	title = {Etude {\'e}pid{\'e}miologique nationale des LAL},
	journal = {Revue Alg{\'e}rienne d{\textquoteright}H{\'e}matologie},
	year = {2016},
	author = {Z Zouaoui and M Benlazar and M Bachiri}
}
@article {6253,
	title = {Outbreak of OXA-48-Producing Klebsiella pneumoniae Involving aSequence Type 101 Clone in Batna University Hospital, Algeria.},
	journal = {Antimicrobial Agents and Chemotherapy},
	volume = {60},
	number = {12},
	year = {2016},
	pages = {7494},
	abstract = {
	
		
			Seven nonredundant ertapenem-resistant\&nbsp;Klebsiella pneumoniae\&nbsp;isolates were collected between May 2014 and 19 January 2015 in the nephrology and hematology units of Batna University Hospital in Algeria. All strains coproduced the\&nbsp;blaOXA-48,\&nbsp;blaCTX-M-15,\&nbsp;blaSHV-1, and\&nbsp;blaTEM-1D\&nbsp;genes. Six of these isolates belonged to the pandemic clone sequence type 101 (ST101). The\&nbsp;blaOXA-48\&nbsp;gene was located on a conjugative IncL/M-type plasmid. This is the first known outbreak of OXA-48-producing\&nbsp;K. pneumoniae\&nbsp;isolates involving an ST101 clone in Batna University Hospital.
		
	

},
	author = {Lotfi Loucif and Ahmed Kassah-Laouar and Mahdia Saidi and Amina Messala and Widad Chelaghma and Jean-Marc Rolain}
}
@article {6251,
	title = {Descriptive Study of Diffuse Large B Cell Lymphoma in Algeria and Tunisia over a Period of 5 Years},
	journal = {Blood},
	volume = {128},
	number = {22},
	year = {2016},
	pages = {5412},
	abstract = {
	Background: Diffuse Large B Cell Lymphoma (DLBCL) is the most common form of aggressive non-Hodgkin{\textquoteright}s lymphoma (NHL) accounting for approximately 40 \% of all NHL cases. The aim of our study is to carry out an epidemiologic description and to compute the incidence of DLBCL in 2North African countries, Algeria and Tunisia.



	Patients and methods: This is a multicenter retrospective and descriptive study, covering a period of 5 years (January 2010 - December 2014), carried out in 17 centers in Algeria and 5 centers in Tunisia. Patients aged less than 15 years were excluded. We used the classification of World Health Organization. We used Epi info 6 software to analyze the data.



	Results: 1432 cases were identified, 1175 in Algeria and 257 in Tunisia. The sex distribution of DLBCL was as follows: males 837 (58.4 \%), females 591 (41.6 \%), male-to-female ratio 1.40. The age of patients ranged from 16 to 96 years (median 52 years) and 64.2 \% of the patients are less than 60. The incidence estimates for the years 2012 and 2013 are respectively 0.86 and 0.87 for 100,000 inhabitants. The most frequent occupation of the cases is farmworker (11.5\%). The average time between the date of diagnosis and clinical examination is 31 days. The average delay between the first clinical sign and the date of diagnosis is 133 days. A familial history of cancer is found in 10\% of the cases. The lymph node biopsy was undertaken in 30.7\% of the cases in the cervical area and in 15\% of cases in the mediastinal area. A reexamination of the slides was undertaken in 20\% of cases while 61.6\% of them were found to be advanced clinical stages (III + IV). Splenomegaly was found in 16\% of the cases and hepatomegaly in 7\%. ORL damage was found in 16\% of the cases and marrow infiltration in 10.2\%. A Prognostic Score IPI >= 2 is found in 38\% of the patients.



	Comments:\&nbsp;On a previous Algerian study concerning all lymphomas diagnosed over a period of 6 years (2007-2012) (Journal of Hematology No. 10-11, 2015), 485 new cases of lymphoma were diagnosed on average per year. In the present study, the average number of new cases of DLBCL was 235 and the average proportion was 48\% of all lymphomas. It should be emphasized that all cases underwent an immunohistochemical study and that lymphatic cases were excluded (digestive, bone, skin). The national incidence rate is low compared to that of international studies, a fact that is probably due to difficulties in the diagnosis including lack of implementation of immunohistochemistry techniques in our region.



	Disclosures



	No relevant conflicts of interest to declare.

},
	author = {N Boudjerra and S Oukid and Abad, MT and C Aboura and L Louanchi and M Ramaoun and M Belhani and M Allouda and H Aftisse and H Ait-Ali and R Ben lakhal and B Meddeb and N Ait-Ameur and F Belhadri and F Tensaout and R Ahmed Nacer and Hamladji, RM and S Bougherira and Malek Benakli}
}
@article {6246,
	title = {Epidemiology of Extranodal Diffuse Large B Cell Lymphomas in Algeria: A Study of the Algerian Group of Extranodal Lymphomas (GALEG)},
	journal = {Blood},
	volume = {128},
	number = {22},
	year = {2016},
	pages = {5403},
	abstract = {
	Introduction:\&nbsp;Primitive extranodal lymphomas are a heterogeneous group of malignant lymphoid hematological developed from the mucosa-associated lymphoid tissue (MATL) or sites that have acquired MALT after repeated stimulation. The particularity of this type of affection reside: the access to diagnosis which is difficult and therapeutic approach which respond to the ATB, antiviral, surgery and RT. They represent 24-48\% of lymph node lymphomas and they are increasing. The incidence of lymphoma is growing in the world, it is approximately 16.8 / 105inhabitants. In Algeria in 2012, the incidence of lymph node lymphomas in adults was 2.24 / 100,000. Lymphomas Diffuse large B-cell phenotype (DLBCL) represent 50-60\% of lymphomas, it is the most common histological type.



	Goals of the study:



	1-analyze the epidemiological characteristics (gender, age, geographical distribution, annual incidence). 2- Identify anatomical sites. 3- Specify the clinical and prognostic features



	Patients and methods:\&nbsp;It{\textquoteright}s is a multicenter, retrospective study over a period between 2010-2014. The study population included all pts over 15 years and having an extranodal DLBCL at 18 hematology centers and 4 cancer centers. Data were collected on data sheets distributed to the various services involved in the study. The diagnosis is made on the histological examination of a biopsy of the affected organ. The clinical, biological and imaging results allowed us to classify and identify prognostic factors for pts.



	Results:\&nbsp;Among 1057 sheets of extranodal lymphomas, the type DLBCL is specified in 562 (53\%) cases, distributed in 325 men and 237 women (sex ratio M/F: 1.36). The average age at diagnosis is 51 years (16-88) with a peak in the age group 50-60 years. The overall annual incidence of 0.31/105\&nbsp;inhabitants/year and the specific incidence for patients over 15 years is 0.42 / 105inhabitants/year. PS 0-1: 323 / 543pts (60\%). Number of pts (pts) by place of care: Annaba 65, S{\'e}tif: 60, CAC Constantine: 53, Tizi Ouzou: 49, Blida Cac: 41, CMPC-hematology: 40, Tlemcen: 30, Beni- M{\'e}ssous- hematology: 29, CAC CPMC: 24, EHUOran: 23, hematology CAC Batna: 22, CHU Oran: 19, HMRUO: 17, Blida-hematology: 16, HCA:16, SBA: 15, CAC B{\'e}ni-Messous: 14, EPH Mascara: 10, HMRU Oran: 9, Bejaia: 7, hematology CHU Batna: 2, hematology Cne:1. Number of cases according to anatomical localisation: Stomach: 180, Intestine: 31, Colon 12, Tonsils: 70, Cavum: 31, nasal cavities: 11, Bones: 43, mediastinum: 41, SNC: 29, Skin: 25, Rate / MO :15, Thyroid: 12, soft Parties: 10, Breast: 6, lung / pleural: 5, Liver: 5, Others: 36. The clinical symptomatology is very heterogeneous, specifically of the affected organ. Clinical stage is specified in 549 cases, according to Ann Arbor: SCIE: 272 (49\%), SCIIE: 149 (27\%), SCIIIE: 31 (6\%), SCIV: 97 (18\%). The International Prognostic Index adjusted for age (IPIaa) include: for pts less than 60 years: Low (F): 70 (23\%), lower intermediate (IF): 130 (43\%), intermediate high (IE) : 69 (23\%), high (H): 32 (11\%); for over 60 years Topics: F: 33 (23\%), MI: 53 (37\%) IE: 41 (28\%), E: 17 (12\%).



	Comments:\&nbsp;As with other types of lymphoma, there is a male predominance and a peak incidence in the age group 50-60 years. The higher number of pts in the center and east of the country is probably related to a denser population in these regions. The histological type DLBCL at 53\% is in agreement whith what it is conventionally reported. The incidence of 0.31/105inhabitants/year extranodal DLBCL is lower than the overall nodal DLBCL, however, the incidence of extranodal NHL is rarely determined. The number of cases of extranodal lymphomas described in this study is certainly below the actual number because this group of disorders is supported by various specialties related to the location of lymphoma. Extranodal lymphomas has a clinical polymorphism, but it is recognized that gastric and tonsillar locations are the most common, the other despite their rarity, require attention from management. This type of lymphoma is characterized by a preponderance of localized stages unlike ganglion lymphomas where the extended stages predominate. Likewise distribution by IPIaa not exceeding one pejorative factor is more common.



	Conclusion:\&nbsp;Extranodal DLBCL are rare, they are characterized by a diversity clinicopathological that challenges us to homogenization of their treatment in multidisciplinary level.



	Disclosures



	No relevant conflicts of interest to declare.

},
	author = {Hamdi, S and I Bentahar and H Harbadji and Fatiha Grifi and S Bougherira and T Filali and M Allouda and N Mesli and B Berber and K Bouzid and R Sai and Hamladji, RM and R Ahmed Nacer and N Ait-Ameur and F Belhadri and Malek Benakli}
}
@article {6245,
	title = {Epidemiological Approach of Chronic Myeloid Leukemia. Algerian-Tunisian Study},
	journal = {Blood},
	volume = {128},
	number = {22},
	year = {2016},
	pages = {5440},
	abstract = {
	Introduction: Chronic myeloid leukemia (CML) accounts for 7\%-15\% of all leukemias affecting adults. The incidence in Algeria is 0.4/100,000 inhabitants in 2009. The aim of this study is to establish an Algerian-Tunisian epidemiological approach of CML and to know the characteristics of the disease in both countries.



	Materials and methods: This is a retrospective, longitudinal and multicenter study, including Algerian and Tunisian patients with CML diagnosed between January 2010 and December 2014. Through a data form distributed to various hematology departments, we collected and analyzed the following information: Patient{\textquoteright}s general characteristics, profession, circumstances of discovery of the disease, clinical and para-clinical examinations outcomes at the time of diagnosis including blood count, blood smear, bone marrow aspiration, cytogenetics, molecular biology, stages of the disease and the Sokal and Eutos prognostic classification scores. Bio-statistical tests: incidence, prevalence and rate of prevalence or relative prevalence (reported to 100,000 inhabitants / year). The descriptive analysis of quantitative and qualitative variables as percentages and 95\% confidence interval. The Chi2 test is used to compare two variables.



	Results: We collected 1349 cases, including 325 from 06 Tunisian hematology units and 1024 from 18 Algerian units. The incidence in the Algerian-Tunisian population was 0.67/100,000 inhabitants with a prevalence rate of 2.72/100,000 inhabitants. The incidence in Tunisia was 0.50 / 100,000 inhabitants with a prevalence of 227 cases in 2014. In Algeria the incidence was 0.53/100,000 inhabitants with a prevalence of 1030 in 2014. The median age is 48 years (03-90) with a peak incidence in the age group (45-49 ans) and slight male predominance (sex ratio: 1,2). There was any notion of risk exposure. The average time between the start of the unrest and the date of diagnosis is 127 days (1-667). The circumstances of discovery: fortuitous in 30.5\% (n = 355), splenomegaly in 39.7\% (n = 463), asthenia in 24.6\% (n = 287), a complication in 8.4\% (n =95). Clinical examination includes general signs in 424 cases (36.4\%): Weight loss 22.6\% (n = 263), profuse sweating 13.8\% (n = 13, 8\%), bone pains found in 7.8\%, splenomegaly in 81.7\% (n = 952) with an overhang splenic average of 11.5 {\textpm} 5.3 cm (1-28), cutaneous and subcutaneous bleeding: 13.5\% (n = 97), thrombosis 0.9\% (n = 09). Biological characteristics: the Complete blood count (n = 1185) shows a white blood cells average rate of 171,223 G/L (34,700-984,800), hemoglobin average rate of 10.2 g/dl (4-17), platelets at 394,070 g/l (85-1340). Blood smear 96.3\% (n = 1121): the average myelemia was 43.2\% (10-98\%). The Myelogram is practiced in 55\% (n = 641), the average rate of the granular 76,5\% (40-99\%), erythroblasts 10.5\% (0-82\%), average blasts 3.6\%. The karyotype 38.1\% (n = 444), the Philadelphia chromosome was found in 423 cases (95, 3\%); additional abnormalities were found in 17 cases (3.8\%). The Fish was practiced in 281 cases (24.1\%) and transcribed bcr/abl was found in 257 cases (91.4\%). Molecular biology is practiced in 672 cases (57.7\%) the transcript bcr/abl is found in 100\%, the transcript of the type is specified in 373 cases, it is kind of b2a2 in 159 cases (42.6\%), a b3a2 type in 180 cases (48.3\%) and other transcribed in 34 cases (9.1\%). CML chronic phase is diagnosed in 88.8\% (n = 1051), acceleration phase in 9\% (n = 107) acutisation phase in 3.1\% (= 37). The distribution of pts according to Sokal prognostic classification (n = 948) describes a predominance of intermediate risk in 54\% (n = 511), high risk in 30.3\% (n = 287) and low risk in 16\% (n = 152). The Eutos score is specified in 769 cases (66\%), it is less than 87 in 661 cases (86\%) and more than 87 in 108 cases (14\%).



	Conclusion:\&nbsp;The incidence of CML in the Algerian-Tunisian population is 0.67/100,000 population with a prevalence rate of 2.72/100,000 inhabitants. The young adult is more affected with a peak incidence between 45 and 49. The average time between the onset of the disease and the diagnosis remains long and the delay probably explains the frequency of tumor forms encountered in Algeria and the prevalence of high and intermediate risk, according to Sokal prognostic classification.



	Disclosures



	No relevant conflicts of interest to declare.

},
	author = {Djouadi, K and Abdennebi, N and Harieche, F and R Ahmed-Nacer and Hamladji, RM and Bouchakour, A and Taoussi, S and Abad, MT and Touil, Fz and Hamdi, S and S Bougherira and Fatiha Grifi and C Kerrar and I Allam and O Djidjik and N Boudjerra and M Belhani and S Gherras and Malek Benakli}
}
@article {6236,
	title = {Spectrophotometric Determination of Chromium, Copper, Nickel and Iron in Electroplating Hydroxide Sludges},
	journal = {Asian journal of Chemistry},
	volume = {28},
	number = {5},
	year = {2016},
	pages = {1079-1083},
	author = {M Boudjouada and Salhi Ramdane and S Bekhbekh and A Kabouche and N Gherraf}
}
@article {6235,
	title = {Recovery of nickel and copper from metal finishing hydroxide sludge by kinetic acid leaching},
	journal = {Journal of New Technology and Materials },
	volume = {06},
	number = {02},
	year = {2016},
	pages = {62-71},
	author = {Salhi Ramdane and M Boudjouada and S Messikh and N Gherraf}
}
@booklet {3764,
	title = {Epidemiological approach of chronic myeloid leukemia. Algerian-tunisian study},
	year = {2016},
	publisher = {American Society of Hematology Washington, DC},
	isbn = {0006-4971},
	author = {Djouadi, K and Abdennebi, N and Harieche, F and R Ahmed-Nacer and Hamladji, RM and Bouchakour, A and Taoussi, S and Abad, MT and Touil, Fz and Hamdi, S}
}
